Zhou Q - Search Results

1

Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and humans in vitro.

Jing R, Zhou X, Zhao J, Wei Y, Zuo B, You A, Rao Q, Gao X, Yang R, Chen L, Lu Z, Zhou Q, Zhang N, Yin H. Jing R, et al. Among authors: zhou x, zhou q. Hepatology. 2018 Oct;68(4):1391-1411. doi: 10.1002/hep.29829. Epub 2018 May 21. Hepatology. 2018. PMID: 29405333

2

Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice.

Zuo B, Qi H, Lu Z, Chen L, Sun B, Yang R, Zhang Y, Liu Z, Gao X, You A, Wu L, Jing R, Zhou Q, Yin H. Zuo B, et al. Among authors: zhou q. Nat Commun. 2020 Apr 14;11(1):1790. doi: 10.1038/s41467-020-15569-2. Nat Commun. 2020. PMID: 32286296 Free PMC article.

3

For Better or Worse, Iron Overload by Superparamagnetic Iron Oxide Nanoparticles as a MRI Contrast Agent for Chronic Liver Diseases.

Zhou Q, Wei Y. Zhou Q, et al. Chem Res Toxicol. 2017 Jan 17;30(1):73-80. doi: 10.1021/acs.chemrestox.6b00298. Epub 2016 Nov 17. Chem Res Toxicol. 2017. PMID: 28092939

4

Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy.

Gao X, Ran N, Dong X, Zuo B, Yang R, Zhou Q, Moulton HM, Seow Y, Yin H. Gao X, et al. Among authors: zhou q. Sci Transl Med. 2018 Jun 6;10(444):eaat0195. doi: 10.1126/scitranslmed.aat0195. Sci Transl Med. 2018. PMID: 29875202

5

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses.

Zuo B, Zhang Y, Zhao K, Wu L, Qi H, Yang R, Gao X, Geng M, Wu Y, Jing R, Zhou Q, Seow Y, Yin H. Zuo B, et al. Among authors: zhou q. J Hematol Oncol. 2022 Apr 29;15(1):46. doi: 10.1186/s13045-022-01266-8. J Hematol Oncol. 2022. PMID: 35488312 Free PMC article.

6

pH-responsive pHLIP (pH low insertion peptide) nanoclusters of superparamagnetic iron oxide nanoparticles as a tumor-selective MRI contrast agent.

Wei Y, Liao R, Mahmood AA, Xu H, Zhou Q. Wei Y, et al. Among authors: zhou q. Acta Biomater. 2017 Jun;55:194-203. doi: 10.1016/j.actbio.2017.03.046. Epub 2017 Mar 29. Acta Biomater. 2017. PMID: 28363789

7

In vitro naphthylquinoxaline thymidine conjugate and UVA treated cancer cells are effective therapeutic vaccines for tumors in vivo with CpG as the adjuvant.

Yang R, Zhou S, Zhou Q. Yang R, et al. Among authors: zhou q, zhou s. J Adv Res. 2021 Mar 9;35:259-266. doi: 10.1016/j.jare.2021.03.003. eCollection 2022 Jan. J Adv Res. 2021. PMID: 35003803 Free PMC article.

8

Naphthyl quinoxaline thymidine conjugate is a potent anticancer agent post UVA activation and elicits marked inhibition of tumor growth through vaccination.

Yuan Y, Wang Z, Yang R, Qian T, Zhou Q. Yuan Y, et al. Among authors: zhou q. Eur J Med Chem. 2019 Jun 1;171:255-264. doi: 10.1016/j.ejmech.2019.03.051. Epub 2019 Mar 23. Eur J Med Chem. 2019. PMID: 30925340 Free article.

9

Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment.

Wei Y, Zhao M, Yang F, Mao Y, Xie H, Zhou Q. Wei Y, et al. Among authors: zhou q. Sci Rep. 2016 Jun 30;6:29110. doi: 10.1038/srep29110. Sci Rep. 2016. PMID: 27357559 Free PMC article.

10

cRGD target liposome delivery system promoted immunogenic cell death through enhanced anticancer potency of a thymidine conjugate under UVA activation as a cancer vaccine.

Yang R, Wang Z, Yuan Y, Qian T, Zhou Q. Yang R, et al. Among authors: zhou q. Eur J Med Chem. 2019 Apr 1;167:499-509. doi: 10.1016/j.ejmech.2019.02.031. Epub 2019 Feb 13. Eur J Med Chem. 2019. PMID: 30784882 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,175 results

Search Page

Filters